PMID- 31544528 OWN - NLM STAT- MEDLINE DCOM- 20200409 LR - 20200409 IS - 1360-046X (Electronic) IS - 0268-8697 (Linking) VI - 33 IP - 6 DP - 2019 Dec TI - Impact of transsphenoidal surgery for pituitary adenomas on overall health-related quality of life: a longitudinal cohort study. PG - 635-640 LID - 10.1080/02688697.2019.1667480 [doi] AB - Background: Previous studies show a moderate improvement in health-related quality of life (HRQoL) following transsphenoidal surgery for pituitary adenomas, but no consistent predictors of HRQoL outcome have been identified. We aimed to evaluate overall HRQoL changes following such surgery, and assess potential patient or tumour characteristics that predict HRQoL outcome.Materials and methods: Sixty adult patients undergoing transsphenoidal resection of pituitary adenomas were prospectively enrolled. They completed the EQ-5D 3L, a generic HRQoL questionnaire, preoperatively, and at one (n = 57) and six months (n = 56) postoperatively. HRQoL was assessed as both postoperative change in median EQ-5D 3L score, and as change greater than the minimal clinically important difference (MCID) in EQ-5D 3L score. A multivariable logistic regression analysis was performed to assess potential predictors of clinically significant HRQoL changes (>MCID) at six months postoperatively.Results: There was a slight, but statistically significant, improvement in median EQ-5D 3L scores at six months postoperatively compared to preoperatively. Sixteen patients (29%) reported a clinically significant improvement in HRQoL at six months postoperatively, and larger preoperative tumour volume was a statistically significant predictor of such improvement. Eight patients (14%) reported a clinically significant deterioration in HRQoL at six months, but none of the assessed variables predicted such deterioration.Conclusions: Patient-reported overall HRQoL improved slightly after transsphenoidal surgery for pituitary adenomas at group level. Patients with larger tumours might have more HRQoL benefits from surgery, but the mechanisms behind the predictive nature of tumour volume remain unknown. FAU - Sommerfelt, Hanne AU - Sommerfelt H AUID- ORCID: 0000-0001-5068-6029 AD - Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. FAU - Sagberg, Lisa Millgard AU - Sagberg LM AD - Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. AD - Department of Neurosurgery, St. Olav s University Hospital, Trondheim, Norway. AD - Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy, St. Olav s University Hospital, Trondheim, Norway. FAU - Solheim, Ole AU - Solheim O AD - Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. AD - Department of Neurosurgery, St. Olav s University Hospital, Trondheim, Norway. AD - Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy, St. Olav s University Hospital, Trondheim, Norway. LA - eng PT - Journal Article DEP - 20190922 PL - England TA - Br J Neurosurg JT - British journal of neurosurgery JID - 8800054 SB - IM MH - Adenoma/*surgery MH - Adult MH - Aged MH - Cohort Studies MH - Female MH - Follow-Up Studies MH - Humans MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Neurosurgical Procedures/adverse effects/*methods MH - Pituitary Neoplasms/*surgery MH - Postoperative Complications/epidemiology MH - Prospective Studies MH - Quality of Life MH - Sphenoid Bone/*surgery MH - Surveys and Questionnaires MH - Treatment Outcome OTO - NOTNLM OT - Patient-reported outcome measures OT - pituitary adenoma OT - pituitary surgery OT - quality of life EDAT- 2019/09/24 06:00 MHDA- 2020/04/10 06:00 CRDT- 2019/09/24 06:00 PHST- 2019/09/24 06:00 [pubmed] PHST- 2020/04/10 06:00 [medline] PHST- 2019/09/24 06:00 [entrez] AID - 10.1080/02688697.2019.1667480 [doi] PST - ppublish SO - Br J Neurosurg. 2019 Dec;33(6):635-640. doi: 10.1080/02688697.2019.1667480. Epub 2019 Sep 22.